Cargando…
Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo
Esophageal squamous cell carcinomas (ESCC) have become a severe threat to health and the current treatments for ESCC are frequently not effective. Recent epidemiological studies suggest that the anti-hyperglycemic agent metformin may reduce the risk of developing cancer, including ESCC, among diabet...
Autores principales: | Cai, Xianbin, Hu, Xi, Tan, Xiaojun, Cheng, Weijie, Wang, Qinjia, Chen, Xiaofeng, Guan, Yinghong, Chen, Chong, Jing, Xubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510392/ https://www.ncbi.nlm.nih.gov/pubmed/26196392 http://dx.doi.org/10.1371/journal.pone.0133349 |
Ejemplares similares
-
Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway
por: He, Yindi, et al.
Publicado: (2018) -
Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study
por: Peng, Jianwei, et al.
Publicado: (2020) -
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
por: Wang, Yan, et al.
Publicado: (2018) -
TERT promoter regulating melittin expression induces apoptosis and G(0)/G(1) cell cycle arrest in esophageal carcinoma cells
por: Zhou, Chao, et al.
Publicado: (2021) -
Tectorigenin Inhibits Glioblastoma Proliferation by G0/G1 Cell Cycle Arrest
por: Yeh, Liang-Tsai, et al.
Publicado: (2020)